The USFDA has completed an inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of Granules India located in Chantilly, Virginia, the USA on July 22, 2022 with six observations. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.
Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).
